Matthew A. Morgan

Dextran-Coated Cerium Oxide Nanoparticles: A Computed Tomography Contrast Agent for Imaging the Gastrointestinal Tract and Inflammatory Bowel Disease

Pratap C. Naha, Jessica C. Hsu, Johoon Kim et al. · ACS Nano · 2020 · 168 citations · Full text

Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer

Matthew A. Morgan, Wyn G. Lewis, Andrew N. Hopper et al. · Diseases of the Esophagus · 2006 · 59 citations · Full text

Body Mass Indices, Surgical Oncology, Esophageal Cancer +18

High molecular weight cytokeratin antibody (clone 34βE12): a sensitive marker for differentiation of high‐grade invasive urothelial carcinoma from prostate cancer

Murali Varma, Matthew A. Morgan, Mahul B. Amin et al. · Histopathology · 2003 · 58 citations

Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma

Matthew A. Morgan, Wyn G. Lewis, Angela Casbard et al. · British journal of surgery · 2009 · 56 citations · Full text

Evaluation of automated silver‐enhanced <i>in situ</i> hybridization (SISH) for detection of <i>HER2</i> gene amplification in breast carcinoma excision and core biopsy specimens

Sami Shousha, David Peston, B.K. Amo-Takyi et al. · Histopathology · 2009 · 48 citations